Artemis Medicare Services Limited has announced an earnings conference call for investors and analysts to discuss the company's operational and financial performance for Q4 and FY26. The call is scheduled to be held on Monday, May 11, 2026, at 11:00 AM IST, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was communicated via an official intimation signed by Poonam Makkar, Company Secretary and Compliance Officer, dated May 5, 2026.

Conference Call Details

The earnings call will be hosted by Anand Rathi Research. The following table summarises the key details of the scheduled event:

Key Participants

Senior leadership from Artemis Medicare Services will be present on the call to address queries from investors and analysts:

• Dr. Devlina Chakravarty — Managing Director
• Mr. Sanjiv Kumar Kothari — Chief Financial Officer
• Mr. Rudra Narayan Acharjee — Head – Investor Relations, M&A and Organization Growth Strategy

Access Details

Participants can join the conference call through the following dial-in numbers:

For further information, participants may contact the call co-ordinator, Himanshu Binani, at Office No: (022) 6626 6712 or Mobile: 7381039698. The company has noted that the schedule is subject to changes in case of exigencies on the part of analysts, investors, or the company.

Artemis Medicare Services has informed the stock exchanges of a forthcoming Board of Directors meeting scheduled for May 8, 2026 (Friday), pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting has been convened to consider key financial and shareholder-related matters for the quarter and year ended March 31, 2026.

Key Agenda Items

The board meeting has been called to address two primary matters, as outlined in the company's exchange filing dated May 5, 2026:

• Approval of Audited Financial Results: The board will consider and approve the Audited Financial Results on both a Standalone and Consolidated basis for the quarter and year ended March 31, 2026.
• Dividend Recommendation: The board will deliberate on recommending a dividend, if any, on the equity shares of the company for the year ended March 31, 2026.

Meeting and Trading Window Details

The following table summarises the key details related to the board meeting and the associated trading window closure:

Trading Window Closure

As communicated by the company vide its earlier intimation dated March 30, 2026, the trading window for dealing in the securities of Artemis Medicare Services was closed from April 1, 2026. The window shall remain closed until 48 hours after the declaration of audited financial results, i.e., up to May 10, 2026 (both days inclusive). This closure is in accordance with the applicable insider trading regulations.

The intimation was signed by Poonam Makkar, Company Secretary & Compliance Officer, on behalf of Artemis Medicare Services Limited.